Cardiol Therapeutics Files 6-K with News Release
Ticker: CRDL · Form: 6-K · Filed: Jun 27, 2024 · CIK: 1702123
| Field | Detail |
|---|---|
| Company | Cardiol Therapeutics INC. (CRDL) |
| Form Type | 6-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, news-release, sec
TL;DR
Cardiol Therapeutics dropped a 6-K filing with a news release attached - check it out.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on June 27, 2024, reporting a news release as an exhibit. The company, based in Oakville, Ontario, Canada, operates in the biological products sector and is subject to SEC file number 001-40712.
Why It Matters
This filing indicates that Cardiol Therapeutics is disseminating important company news, which could impact investor decisions and the company's stock performance.
Risk Assessment
Risk Level: low — A 6-K filing typically contains routine information or news releases and does not inherently signal significant financial distress or major corporate events.
Key Numbers
- 001-40712 — SEC File Number (Identifies the company's registration with the SEC.)
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- 001-40712 (dollar_amount) — SEC File Number
- 20240627 (dollar_amount) — Filing Date
- June 2024 (dollar_amount) — Reporting Period
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information that Cardiol Therapeutics Inc. has made or is required to make public in Canada, has filed or is required to file with any stock exchange, or has distributed or is required to distribute to its security holders.
What is included as an exhibit with this filing?
Exhibit 99.1, a News Release, is submitted herewith.
What is Cardiol Therapeutics Inc.'s principal executive office address?
Cardiol Therapeutics Inc.'s principal executive office is located at 602-2265 Upper Middle Road East, Oakville, Ontario, Canada L6H 0G5.
Does Cardiol Therapeutics Inc. file annual reports under Form 20-F or Form 40-F?
Cardiol Therapeutics Inc. indicates it files annual reports under Form 20-F.
What is the SIC code for Cardiol Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Cardiol Therapeutics Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 229 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2024-06-27 16:01:35
Filing Documents
- form6k.htm (6-K) — 5KB
- exhibit99-1.htm (EX-99.1) — 12KB
- exhibit99-2.htm (EX-99.2) — 15KB
- exhibit99-1xu001.jpg (GRAPHIC) — 8KB
- exhibit99-2x001.jpg (GRAPHIC) — 7KB
- 0001062993-24-013095.txt ( ) — 54KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CARDIOL THERAPEUTICS INC. (Registrant) Date: June 27, 2024 By: /s/ Chris Waddick Chris Waddick Title: Chief Financial Officer